InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.399
+0.259 (6.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$381,577
Profits / Employee
-$524,353
Market Cap
3.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ReShape Lifesciences | 29 |
Theriva Biologics | 22 |
Azitra | 10 |
NLS Pharmaceutics AG | 7 |
GlucoTrack | 6 |
Titan Pharmaceuticals | 4 |
Alaunos Therapeutics | 1 |
INM News
- 3 days ago - InMed Announces Results of 2024 Annual General Meeting - Newsfile Corp
- 4 days ago - InMed Enters Into Standby Equity Purchase Agreement - Newsfile Corp
- 4 weeks ago - InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile Corp
- 5 weeks ago - InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 6 weeks ago - InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules - Newsfile Corp
- 6 weeks ago - InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules - Newsfile Corp
- 7 weeks ago - InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease - Newsfile Corp
- 2 months ago - InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease - Newsfile Corp